Immunocore
Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy.
Our mission is to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating medicines.
Built on our proprietary ImmTAX platform, we have a diverse pipeline of bispecific therapies across a broad range of indications, including multiple cancers, HIV and HBV.
Why Immunocore?
Join us and you’ll be part of a team of outstanding people who pioneer the research, development and delivery of bi-specific TCR therapies, changing lives for the better.
Because we take therapies from the lab bench all the way to the patient bedside, we’ve got a wide range of careers here. Whatever department you join us in, you’ll be part of a high-performing team, and, in return, we’ll give you all the development, training and feedback you need to succeed.
